Sponsor(s): Sponsoring Section/Society: ASA-BIOPHARM
Session Time: 4:00- 5:50 Sunday
Estimated Audience Size: 200-250
A/V Request: none
Theme Session: no Applied Session: yes
Session Title: Immunogenicity and Efficacy Issues in Vaccine Clinical Trials
Organizer: Lachenbruch, Peter A.
Session Timing: Opening Remarks by Chair-5 minutes First Speaker - 25 minutes Second Speaker - 25 minutes Third Speaker - 25 minutes Discussant - 15 minutes Floor Discussion - 15 minutes
1. Time-to-Event Models For Vaccine Studies: Old Answers to New Questions Moulton, Lawrence H.
2. A Theroretical Framework for the Relationship of Correlates of Protection, Population Immunogenicity, and Vaccine Efficacy Kohberger, Robert C.
3. Issues in Predicting the Duration of Vaccine Induced Protection Bohidar, Norman R.
Discussant: Lachenbruch, Peter A.
List of speakers who are nonmembers: None